Association of Remote Technology Use and Other Decentralization Tools with Patient Likelihood to Enroll in Cancer Clinical Trials

JAMA Network Open: Association of Remote Technology Use and Other Decentralization Tools with Patient Likelihood to Enroll in Cancer Clinical Trials

A study by the American Cancer Society Cancer Action Network found that cancer clinical trials leveraging remote technology and decentralization tools to reduce patient time and travel burden associated with participation may increase the patient consent and participation rate. Conducted between July 6 and September 8, 2021, a 41-question, cross-sectional, internet-based survey was administered to cancer patients and survivors in the US who had been diagnosed with or treated for cancer in the past seven years. The study found that self-reported patient disposition toward enrollment in cancer clinical trials increased for modifications using remote technology and other decentralization tools. These findings suggest that greater adoption of practices that reduce patient time and travel burden associated with clinical trial participation could improve enrollment in cancer trials.